We just received data on a new analyst forecast for $LYCA. Sam Slutsky from LifeSci Capital set a price target of 48.0 for LYCA.
To track analyst ratings and price targets for $LYCA, check out Quiver Quantitative's $LYCA forecast page.
Should you buy $LYCA?
Some analysts are better than others. To view the past performance of LifeSci Capital, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$LYCA Price Targets
Multiple analysts have issued price targets for $LYCA recently. We have seen 3 analysts offer price targets for $LYCA in the last 6 months, with a median target of $48.0.
Here are some recent targets:
- Gavin Clark-Gartner from Evercore ISI Group set a target price of $43.0 on 11/17/2026
- Faisal Khurshid from Jefferies set a target price of $50.0 on 11/17/2026
- Sam Slutsky from LifeSci Capital set a target price of $48.0 on 11/17/2026
$LYCA Insider Trading Activity
$LYCA insiders have traded $LYCA stock on the open market 12 times in the past 6 months. Of those trades, 12 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $LYCA stock by insiders over the last 6 months:
- HEALTHCARE CAPITAL PARTNERS III, L.P. VENROCK has made 12 purchases buying 2,078,749 shares for an estimated $38,522,394 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.